Brubaker submits amicus brief in Purdue Pharma case

In the case of Harrington v. Purdue Pharma, pending before the U.S. Supreme Court, Professor Ralph Brubaker has submitted an amicus brief arguing “Courts have no power to approve” the bankruptcy plan submitted by Purdue Pharma. Joined in writing the brief by fellow bankruptcy experts Professor Bruce Markell of Northwestern and Professor Jonathan Seymour of Duke, Brubaker and his co-amici assert that approval of the Chapter 11 bankruptcy plan from Purdue Pharma is not permissible under established law and would represent a violation of claimants’ due-process rights. The brief suggests that the Court should repudiate the discharge plan in order to “put an end to the abusive ‘bankruptcy grifting’ that this case vividly illustrates.”

Brubaker writes about Purdue Pharma’s appeal for Creditor Rights Coalition

As part of Creditor Rights Coalition’s “The Academics Speak Up” series, Professor Ralph Brubaker shared his thoughts on Purdue Pharma’s appeal to the U.S. Supreme Court in its bankruptcy proceedings. Brubaker made clear his feelings about the mechanisms by which Purdue was trying to discharge its debts in a direct and unsparing critique. “I am grateful for the tenacity of the U.S. Trustee and DOJ in calling out the utter impropriety of nondebtor-discharge practice, which has tainted the bankruptcy system and incited public outrage,” he wrote.

USA Today quotes Brubaker on Rite Aid bankruptcy

In an attempt to restructure its more than $3 billion in debt and confront lawsuits alleging the company filled opioid prescriptions unlawfully, Rite Aid is reportedly preparing to file bankruptcy. In an article examining the company’s motivations for doing so and the potential ramifications of their bankruptcy, USA Today quoted Professor Ralph Brubaker, an expert in bankruptcy law. In his comments, Brubaker explained that customers would see almost no change should the retail chain declare Chapter 11 bankruptcy, but cited the example of Johnson & Johnson as how Rite Aid might not succeed in their efforts to limit liability.

Johnson & Johnson facing uphill battle on bankruptcy, Brubaker tells Bloomberg

Johnson & Johnson’s attempts to use the bankruptcy of its subsidiary, LTL Management LLC, to settle claims that its talc-based products, like baby powder, caused cancer have failed once again, this time in US Bankruptcy Court for the District of New Jersey. In an article on Bloomberg Law, Professor Ralph Brubaker explained that the company’s first attempt to use bankruptcy, which was thrown out by the US Court of Appeals for the Third Circuit, makes an appeal on the second attempt very unlikely “to get much traction.”

Brubaker joins Bloomberg Intelligence podcast

Dating to his days in practice, Professor Ralph Brubaker has long held an interest in mass torts and bankruptcy that has developed into a rich and rewarding scholarly career. He shared his expertise in a feature interview on the Bloomberg Intelligence FICC Focus podcast, speaking in depth about what makes bankruptcy so appealing to defendants and corporate tortfeasors’ persistent efforts to exploit Chapter 11 protections. 

Brubaker in WaPo: The Justice Department was right to object to Purdue’s rotten deal

In an August 28th letter to the editor of The Washington Post, bankruptcy expert and professor Ralph Brubaker strongly condemned the Purdue Pharma settlement plan. He wrote:

There are eminently feasible, well-trodden means of rendering justice for massive iniquity, which can and will produce much better (and actual) settlements for victims, if the Supreme Court repudiates the kind of ad hoc, designer justice system for the wealthy of which the Purdue deal is emblematic.”

Washington Post quotes Brubaker on Purdue Pharma Bankruptcy case

The proposed bankruptcy plan for Purdue Pharma, which would allocate billions of dollars to help ease the nation’s opioid crisis but shield the Sackler family from future lawsuits, has been placed on hold by the Supreme Court. Speaking to The Washington Post, Professor Ralph Brubaker, an expert in bankruptcy law, called the case one of the most important bankruptcy cases to ever come before the Court “from both a practical and a fundamental-justice perspective.” Appellate courts have long been divided on whether those who haven’t declared bankruptcy, such as the individuals in the Sackler family, can be “released” from potential lawsuits through a bankruptcy reorganization, setting up a potentially precedent-setting opinion from the Supreme Court.

Manhattan Bankruptcy Court cites Brubaker in Holiday Inn decision

In his decision this week, Judge Philip Bentley of the U.S. Bankruptcy Court in Manhattan ruled a bankrupt Holiday Inn in downtown Manhattan can’t use chapter 11 to maintain its low-rate mortgage without paying penalty interest linked to its default. The case arose after the owner failed to make payments on its loan after the hotel closed during the pandemic; lenders began charging default interest in response, leading the owner to file for bankruptcy in order to avoid a seizure. The decision cited two articles by Professor Ralph Brubaker from Bankruptcy Law Letter: “Default Rates of Interest and Cure of a Defaulted Debt in a Chapter 11 Plan of Reorganization (Part I): Entz-White’s Overlooked Choice of Law Dimension” (December 2016, Vol. 36, Issue 12) and “Default Rates of Interest and Cure of a Defaulted Debt in a Chapter 11 Plan of Reorganization (Part II): Entz-White and the ‘Penalty Rate’ Amendments” (January 2017, Vol. 37, Issue 1). Writing about the decision, the Wall Street Journal quoted Brubaker, who explained that this ruling could increase the costs for companies that were hoping to reinstate their cheap debt.

College of Law
504 East Pennsylvania Avenue
Champaign, IL 61820
(217) 333-0931